00719.HK
Shandong Xinhua Pharmaceutical Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 5.35
−1.11%Margins
Gross margin
17.9%
EBITDA margin
5.5%
EBIT margin
3.5%
Net margin
2.8%
FCF margin
3.8%
4.3%
Return on equity
2.6%
Return on assets
4.5%
Return on invested capital
0.89x
Asset turnover
HKD 460.7M
Cash from operations
HKD 2.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026